RNTX
RNTX
NASDAQ · Biotechnology

Rein Therapeutics Inc

$0.72
-0.03 (-3.66%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 7 78%
Hold 2 22%
Sell 0 0%
Price Target
Analyst Price Target +6,411.8% upside
Low Target $33.28
Average Target $46.95
High Target $64.49
Current Price $0.72
Current
$0.72
Target
$46.95
$33.28 $46.95 avg $64.49
Scenario Analysis
Bear Case
$33.28
4,515.8%
Low target
Base Case
$46.95
+6,411.8%
Avg target
Bull Case
$64.49
+8,844.5%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$2.18
-66.9% from high
52-Week Low
$0.69
+3.9% from low
Target vs 52W High
$46.95
+2,053.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%